(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

-LDL HDL+

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

-LDL HDL+

ST13

US500000079372661

Classe

5

Pedido

79372661

Registro

7518361

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

33

Atualização mais recente

03/04/2026

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

5

Data de depósito

25/05/2023

Data de registro

01/10/2024

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

01/10/2024

Última transação

03/04/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

3

Tipo de titular

82

Localização do titular

AU

Examinador

AREY, BRANDON LEON

Unidade examinadora

N90

Localização atual

FILE REPOSITORY (FRANCONIA)

Descrição da marca

The mark consists of the following: a red stylized design of a heart with a stylized design of a yellow ECG reading in the middle. Above the foregoing appears a green and grey banner design with stylized arrow designs appearing on either end. On the leftmost end of the banner design appears a white minus symbol followed by the wording "LDL" written in white stylized font. On the rightmost end of the banner design appears the wording "HDL" written in white stylized font followed by a white minus symbol. Other than as previously described the color white represents background and is not claimed as a feature of the mark.

Titulares e representantes

Titulares

Raydel Australia Pty Ltd

Representantes

Justin Lampel LAMPEL LAW, P.C.

Classificação técnica

Classes Nice

Classe 5

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceutical preparations for the treatment of hyperlipidemiaatherosclerosisheart diseasehypertensioncardiometabolic diseasethrombosis and cerebrovascular disease; dietetic food adapted for medical use; dietary supplements for humans; capsulestabletspowderstopical preparations of herbsvitaminsminerals for medicinal use and pharmaceutical purposes for the treatment of hyperlipidemiaatherosclerosisheart diseasehypertensioncardiometabolic diseasethrombosis and cerebrovascular disease; chemico-pharmaceutical preparations for the treatment of hyperlipidemiaatherosclerosisheart diseasehypertensioncardiometabolic diseasethrombosis and cerebrovascular disease; liquid herbal and vitamin dietary supplements; dietetic fooddietary and nutritionally fortified food products adapted for medical purposes; food supplements consisting of amino acidsvitamins and trace elements; food supplementsantioxidants; dietetic beverages containing added herbal extractsvitamins or minerals adapted for medical purposes; pharmaceutical compositions for the treatment of hyperlipidemiaatherosclerosisheart diseasehypertensioncardiometabolic diseasethrombosis and cerebrovascular disease; pharmaceutical preparationsdrug delivery agents in the form of a coating for tablets and capsules that facilitate the delivery of a wide range of pharmaceuticals; pharmaceutical substances for the treatment of hyperlipidemiaatherosclerosisheart diseasehypertensioncardiometabolic diseasethrombosis and cerebrovascular disease; pharmaceutical preparationsgels for the treatment of hyperlipidemiaatherosclerosisheart diseasehypertensioncardiometabolic diseasethrombosis and cerebrovascular disease; plant and herb extractsother than essential oilsfor medical purposes; nutritional supplements; healthcare productsmedicated toothpastemedicated shampoomedicated liquid bath soap; herbal and plant compounds and isolatesother than essential oilsfor medicinal purposes; homeopathic pharmaceutical preparations for the treatment of hyperlipidemiaatherosclerosisheart diseasehypertensioncardiometabolic diseasethrombosis and cerebrovascular disease; medicinal herbs and extracts of medicinal herbsother than essential oils; medicines based on plant extractsother than essential oils; natural healthcare preparationsmedicated toothpastemedicated shampoomedicated liquid bath soap; natural medicinal preparationsmedicated toothpastemedicated shampoomedicated liquid bath soap; medicinal preparations for the mouth to be applied in the form of tablets

Publicações

Histórico de despachos e eventos da marca no USPTO.

33 publicações encontradas

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

19/04/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

08/03/2025

FIMP

FINAL DISPOSITION PROCESSED

08/03/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

01/01/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/10/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

01/10/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

16/07/2024

PUBO

PUBLISHED FOR OPPOSITION

16/07/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

26/06/2024

RNWL

INTERNATIONAL REGISTRATION RENEWED

21/06/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/06/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

07/06/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

07/06/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

07/06/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

07/06/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

27/05/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

27/05/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

27/05/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

29/04/2024

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

29/04/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

29/04/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

29/04/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

29/04/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

29/04/2024

RFNT

REFUSAL PROCESSED BY IB

08/04/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

19/03/2024

RFRR

REFUSAL PROCESSED BY MPU

19/03/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

28/02/2024

CNRT

NON-FINAL ACTION WRITTEN

27/02/2024

DOCK

ASSIGNED TO EXAMINER

20/02/2024

MAFR

APPLICATION FILING RECEIPT MAILED

28/06/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

24/06/2023

SDRC

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

22/06/2023

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace -LDL HDL+ ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.